Re­al Chem­istry de­buts a one-stop dash­board for all things GLP-1

Re­al Chem­istry plans to har­ness the “Wild West” of GLP-1 so­cial me­dia and reams of com­pet­i­tive da­ta in the drug cat­e­go­ry with a new plat­form called IRIS.

An all-in-one dash­board sits at the cen­ter of the ser­vice with re­al-time da­ta that in­clude clin­i­cal tri­al track­ing, script and claims in­for­ma­tion, con­sumer be­hav­iors, pay­er, pol­i­cy and mar­ket ac­cess news, and both paid and un­paid com­mu­ni­ca­tions and me­dia.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER